Unity Biotechnology (UBX) Stock Forecast & Price Target

$1.14 -0.04 (-3.39%)

Closing price 04:00 PM Eastern

Extended Trading

$1.20 +0.06 (+5.61%)

As of 07:50 PM Eastern

Unity Biotechnology - Analysts' Recommendations and Stock Price Forecast (2025)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Buy

Based on 3 Analyst Ratings

Sell
0

Hold
0

Buy
3

Based on 3 Wall Street analysts who have issued ratings for Unity Biotechnology in the last 12 months, the stock has a consensus rating of "Buy." Out of the 3 analysts, 3 have given a buy rating for UBX.

Consensus Price Target

$5.33
367.84% Upside

According to the 3 analysts' twelve-month price targets for Unity Biotechnology, the average price target is $5.33. The highest price target for UBX is $8.00, while the lowest price target for UBX is $4.00. The average price target represents a forecasted upside of 367.84% from the current price of $1.14.

Get the Latest News and Ratings for UBX and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Unity Biotechnology and its competitors.

UBX Analyst Ratings Over Time

Type	Current Forecast 3/28/24 to 3/28/25	1 Month Ago 2/27/24 to 2/26/25	3 Months Ago 12/29/23 to 12/28/24	1 Year Ago 3/29/23 to 3/28/24
Strong Buy	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)
Buy	3 Buy rating(s)	3 Buy rating(s)	2 Buy rating(s)	4 Buy rating(s)
Hold	0 Hold rating(s)	0 Hold rating(s)	0 Hold rating(s)	0 Hold rating(s)
Sell	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)
Consensus Price Target	$5.33	$7.33	$8.00	$6.50
Forecasted Upside	367.84% Upside	326.36% Upside	700.80% Upside	296.34% Upside
Consensus Rating	Buy	Buy	Buy	Buy

Remove Ads

UBX Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

UBX Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Unity Biotechnology Stock vs. The Competition

Type	Unity Biotechnology	Medical Companies	S&P 500
Consensus Rating Score	3.00	2.82	2.54
Consensus Rating	Buy	Moderate Buy	Moderate Buy
Predicted Upside	371.98% Upside	18,958.36% Upside	19.45% Upside
News Sentiment Rating	Neutral News See Recent UBX News	Positive News	Positive News

Remove Ads

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export to Excel

Date	Brokerage	Analyst Name	Action	Rating	Price Target	Upside/Downside on Report Date
3/25/2025	Chardan Capital 1 of 5 stars	D. Gataulin Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Target	Buy ➝ Buy	$6.00 ➝ $4.00	+207.69%
3/24/2025	HC Wainwright 1 of 5 stars	Matthew Caufield Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Target	Buy ➝ Buy	$8.00 ➝ $4.00	+233.33%
8/22/2024	Rodman & Renshaw 1 of 5 stars		Initiated Coverage	Buy	$8.00	+422.87%
11/16/2023	Wedbush Subscribe to MarketBeat All Access for the recommendation accuracy rating	A. Argyrides Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Neutral ➝ Outperform	$4.00	+118.58%
5/26/2023	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target		$5.00 ➝ $6.00	+120.59%
3/28/2023	Mizuho Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Buy	$12.00 ➝ $6.00	+207.69%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Friday at 10:21 PM ET.

UBX Forecast - Frequently Asked Questions

: According to the research reports of 3 Wall Street equities research analysts, the average twelve-month stock price forecast for Unity Biotechnology is $5.33, with a high forecast of $8.00 and a low forecast of $4.00.
: 3 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Unity Biotechnology in the last year. There are currently 3 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" UBX shares.
: According to analysts, Unity Biotechnology's stock has a predicted upside of 367.84% based on their 12-month stock forecasts.
: Unity Biotechnology has been rated by research analysts at Chardan Capital, and HC Wainwright in the past 90 days.
: Analysts like Unity Biotechnology more than other "medical" companies. The consensus rating for Unity Biotechnology is Buy while the average consensus rating for "medical" companies is Moderate Buy. Learn more on how UBX compares to other companies.

Stock Forecasts and Research Tools

Related Companies

Today's Ratings

Top-Rated Stocks

More Ratings Tools

This page (NASDAQ:UBX) was last updated on 3/28/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Unity Biotechnology (UBX) Stock Forecast & Price Target